Compare ARBE & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARBE | DTIL |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.0M | 128.8M |
| IPO Year | N/A | 2019 |
| Metric | ARBE | DTIL |
|---|---|---|
| Price | $0.78 | $5.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $2.38 | ★ $60.00 |
| AVG Volume (30 Days) | ★ 2.3M | 181.6K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,070,000,000.00 |
| Revenue This Year | $446.78 | N/A |
| Revenue Next Year | $300.46 | $34.30 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.76 | $3.53 |
| 52 Week High | $2.88 | $8.82 |
| Indicator | ARBE | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 34.46 | 74.59 |
| Support Level | $0.76 | $4.66 |
| Resistance Level | $1.46 | $5.80 |
| Average True Range (ATR) | 0.08 | 0.33 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 7.71 | 96.39 |
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.